1st Quarter - Report
VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to raising the awareness of Hepatitis C (no specific bill); Issues related to implementation of FDAAA, BIO priorities (Chairmanship) (no specific bill); HR 2552, all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EUSTACIA LEE REIDY | — |
| AMIT K SACHDEV | — |
Medical/Disease Research/Clinical Labs MED
NONE
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMIT K SACHDEV | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.